Every 10-Q that Cbdmd Inc (YCBD) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow YCBD and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full YCBD filings page.
cbdMD, Inc. reported higher sales but continued losses for the quarter and nine months ended June 30, 2026. Total net sales were $5.6 million for the quarter and $16.2 million for the nine months, up 20% and 12% from the prior-year periods, driven by both e‑commerce and wholesale growth and contribution from the Bluebird acquisition.
Gross margin declined to for the quarter and 57.3% for the nine months as wholesale mix, repacking tied to state rule changes, and higher inventory reserves increased cost of sales. The company recorded a nine‑month net loss of $2.2 million and a net loss attributable to common shareholders of $2.4 million, though the latter improved versus the prior year.
Cash was $2.1 million with working capital of $4.7 million, and operating activities used $2.0 million of cash over nine months. Management explicitly states that recurring losses, liquidity needs, and reliance on external financing raise substantial doubt about the company’s ability to continue as a going concern. The company raised capital through new Series C preferred stock and an equity line of credit and completed the $0.9 million Bluebird Botanicals asset acquisition, which added goodwill and new customer relationships. Management highlights significant regulatory uncertainty around federal hemp rules, noting that the Act, if implemented as written, would likely have a material adverse impact on the business.
cbdMD, Inc. reported higher quarterly sales but continued losses and warned about its ability to continue as a going concern. For the quarter ended March 31, 2026, net sales rose to $5.6 million, up from $4.7 million a year earlier, driven by growth in both e‑commerce and wholesale channels and initial contributions from the Bluebird acquisition.
Gross margin declined to 57.7%, and the company posted a net loss attributable to common shareholders of $876,783, though this was an improvement from the prior‑year loss due to lower preferred dividends. For the six‑month period, net sales were $10.7 million with a net loss attributable to common shareholders of $1.2 million. Cash was $2.6 million and working capital $5.4 million as of March 31, 2026, but management highlighted substantial doubt about continuing as a going concern, ongoing preferred dividend obligations, and potentially material adverse impacts from federal hemp legislation.
cbdMD, Inc. reported essentially flat quarterly revenue while remaining unprofitable and warning about its ability to continue as a going concern. For the three months ended December 31, 2025, net sales were $5,016,904, down modestly from $5,113,476 a year earlier.
Gross margin slipped to 59.8% from 66.5% as cost of sales rose, and the company posted a loss from operations of $286,288. Net loss attributable to common shareholders narrowed to $324,602, helped by sharply lower preferred dividends. Adjusted EBITDA was slightly negative at $(35,914).
Cash and cash equivalents increased to $3,387,933 with working capital of about $5.4 million, but management states there is substantial doubt about continuing as a going concern without improved profitability or new funding. To bolster liquidity, cbdMD issued Series B and Series C Convertible Preferred Stock and arranged a $20,000,000 equity line of credit.
The company highlights significant regulatory risk from new federal limits that would cap THC content in hemp-derived consumables nationwide starting November 12, 2026, which it says would likely have a material adverse impact if implemented as written. After quarter end, cbdMD acquired the Bluebird Botanicals brand, expecting roughly $500,000 in additional quarterly revenue once fully integrated.